全文获取类型
收费全文 | 28234篇 |
免费 | 1201篇 |
国内免费 | 290篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 1128篇 |
妇产科学 | 868篇 |
基础医学 | 3154篇 |
口腔科学 | 372篇 |
临床医学 | 2407篇 |
内科学 | 5870篇 |
皮肤病学 | 368篇 |
神经病学 | 2069篇 |
特种医学 | 853篇 |
外国民族医学 | 1篇 |
外科学 | 3997篇 |
综合类 | 2504篇 |
现状与发展 | 1篇 |
预防医学 | 1964篇 |
眼科学 | 370篇 |
药学 | 1928篇 |
136篇 | |
中国医学 | 741篇 |
肿瘤学 | 884篇 |
出版年
2024年 | 30篇 |
2023年 | 230篇 |
2022年 | 511篇 |
2021年 | 813篇 |
2020年 | 701篇 |
2019年 | 1642篇 |
2018年 | 1550篇 |
2017年 | 891篇 |
2016年 | 534篇 |
2015年 | 614篇 |
2014年 | 1173篇 |
2013年 | 1092篇 |
2012年 | 995篇 |
2011年 | 976篇 |
2010年 | 703篇 |
2009年 | 634篇 |
2008年 | 665篇 |
2007年 | 615篇 |
2006年 | 556篇 |
2005年 | 454篇 |
2004年 | 347篇 |
2003年 | 298篇 |
2002年 | 235篇 |
2001年 | 200篇 |
2000年 | 167篇 |
1999年 | 150篇 |
1998年 | 115篇 |
1997年 | 100篇 |
1996年 | 87篇 |
1995年 | 68篇 |
1994年 | 67篇 |
1993年 | 47篇 |
1992年 | 40篇 |
1991年 | 54篇 |
1990年 | 36篇 |
1989年 | 36篇 |
1987年 | 31篇 |
1985年 | 1046篇 |
1984年 | 1784篇 |
1983年 | 1136篇 |
1982年 | 1222篇 |
1981年 | 1191篇 |
1980年 | 987篇 |
1979年 | 890篇 |
1978年 | 824篇 |
1977年 | 693篇 |
1976年 | 791篇 |
1975年 | 555篇 |
1974年 | 498篇 |
1973年 | 559篇 |
排序方式: 共有10000条查询结果,搜索用时 796 毫秒
11.
12.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461
Background
The purpose of the study was to evaluate the association between fetal echocardiographic measurements and the need for intervention (primary coarctation repair, staged coarctation repair, or catheter intervention) in prenatally diagnosed coarctation of the aorta.Methods
A single-centre retrospective cohort study (2005-2015) of 107 fetuses diagnosed with suspected coarctation of the aorta in the setting of an apex-forming left ventricle and antegrade flow across the mitral and aortic valves.Results
Median gestational age at diagnosis was 32 weeks (interquartile range, 23-35 weeks). Fifty-six (52%) did not require any neonatal intervention, 51 patients (48%) underwent a biventricular repair. In univariable analysis, an increase in ascending aorta (AAo) peak Doppler flow velocity (odds ratio [OR], 1.40 [95% confidence interval [CI], 1.05-1.91] per 20 cm/s; P = 0.03) was associated with intervention. No intervention was associated with larger isthmus size (OR, 0.23; P < 0.001), transverse arch diameter (OR, 0.23; P < 0.001), and aortic (OR, 0.72; P = 0.02), mitral (OR, 0.58; P = 0.001), and AAo (OR, 0.53; P < 0.001) z-scores. In multivariable analysis, higher peak AAo Doppler (OR, 2.51 [95% CI, 1.54-4.58] per 20 cm/s; P = 0.001) and younger gestational age at diagnosis (OR, 0.81 [95% CI, 0.70-0.93] per week; P = 0.005) were associated with intervention, whereas a higher AAo z-score (OR, 0.65 [95% CI, 0.43-0.94] per z; P = 0.029) and transverse arch dimension (OR, 0.44 [95% CI, 0.18-0.97]; P = 0.05) decreased the risk of intervention.Conclusions
In prenatally suspected coarctation, the variables associated with intervention comprised smaller AAo and transverse arch size, earlier gestational age at diagnosis, and the additional finding of a higher peak AAo Doppler. 相似文献13.
14.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献15.
作为信息时代一种全新的经济形态,“互联网+”是依托互联网信息技术将互联网技术与传统资源进行重新整合,以优化资源的有效配置、升级业务体系、重新构建商业模式等途径来完成经济转型和更新。“互联网+”时代的到来,深刻影响着各行各业包括教育领域,通过教学新手段的引入,改变了中药药剂学传统的教学方式,更加有利于提高课堂效率,有助于培养新型医药人才,适应社会的发展。 相似文献
16.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
17.
18.
19.
20.